Mutational profile of previously treated chronic lymphocytic leukemia patients progressing on acalabrutinib or ibrutinib
| dc.contributor.author | Woyach, Jennifer A. | |
| dc.contributor.author | Jones, Daniel | |
| dc.contributor.author | Jurczak, Wojciech | |
| dc.contributor.author | Robak, Tadeusz | |
| dc.contributor.author | Illés, Árpád | |
| dc.contributor.author | Kater, Arnon Philip | |
| dc.contributor.author | Ghia, Paolo | |
| dc.contributor.author | Byrd, John C. | |
| dc.contributor.author | Seymour, John F. | |
| dc.contributor.author | Long, Susan | |
| dc.contributor.author | Mohamed, Nehad | |
| dc.contributor.author | Benrashid, Samon | |
| dc.contributor.author | Lai, Tzung-Huei | |
| dc.contributor.author | Jesus, Gary De | |
| dc.contributor.author | Lai, Richard | |
| dc.contributor.author | Bruin, Gerjan de | |
| dc.contributor.author | Rule, Simon | |
| dc.contributor.author | Munugalavadla, Veerendra | |
| dc.date.accessioned | 2024-07-24T10:38:50Z | |
| dc.date.available | 2024-07-24T10:38:50Z | |
| dc.date.issued | 2024 | |
| dc.date.oa | 2025-01-31 | |
| dc.date.pasync | 2025-10-06T23:10:53Z | |
| dc.date.updated | 2024-07-24T10:38:50Z | |
| dc.description.corrector | LB | |
| dc.identifier.citation | Blood. -144 : 10 (2024), p. 1061-1068. -Blood. - 0006-4971 | |
| dc.identifier.doi | http://dx.doi.org/10.1182/blood.2023023659 | |
| dc.identifier.issn | 0006-4971 | |
| dc.identifier.opac | https://ebib.lib.unideb.hu/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM122920 | |
| dc.identifier.scopus | 85196391005 | |
| dc.identifier.uri | https://hdl.handle.net/2437/377067 | |
| dc.identifier.url | https://ashpublications.org/blood/article/doi/10.1182/blood.2023023659/516126/Mutational-profile-of-previously-treated-chronic | |
| dc.language | eng | |
| dc.rights.access | open access article | |
| dc.rights.owner | American Society of Hematology | |
| dc.subject.mab | Orvostudományok | |
| dc.subject.mab | Klinikai orvostudományok | |
| dc.title | Mutational profile of previously treated chronic lymphocytic leukemia patients progressing on acalabrutinib or ibrutinib | |
| dc.type | folyóiratcikk | |
| dc.type | idegen nyelvű folyóiratközlemény külföldi lapban |